Evidence map›Paper›PMID 36378050›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2022

Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.

Fan Xiaoyan, L I Mingzhe, Chen Long, Liang Chao, L U Wenli, Pan Zhiqiang, Jia Dongwei, Peng Peike, Fang Zhaoqin, Liu Xiaomei

Open access · greenAbstract read
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Fan XiaoyanDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
L I MingzheDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Chen LongExperiment Center of Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Liang ChaoDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
L U WenliDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Pan ZhiqiangDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Jia DongweiDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Peng PeikeDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Fang ZhaoqinDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Liu XiaomeiDepartment of Experimental Traditional Chinese Medicine, School of Basic Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Shanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the efficacy of Yuzhizi seed extract (FAQSE) on inhibiting the proliferation of hepatocellular carcinoma (HCC) cells in vitro and to explore the anti-HCC action mechanism of FAQSE.

methodsHuman HCC HepG2 and Huh7 cells were used to investigate the anti-HCC effect of FAQSE. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) method was used to measure cell viability. Affymetrix microarray was adopted to detect the expression of transcriptome. The differentially expressed genes (DEGs) of each cell line were identified. For co-DEGs of both cell lines, the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were enriched using the Database for Annotation, Visualization and Integrated Discovery (DAVID), and the network analysis of protein-protein interaction (PPI) was mapped using the Retrieval of Interacting Genes/Proteins (STRING) and Cytoscape software. Some important genes in the PPI network of co-DEGs were selected to verify by quantitative real-time reverse transcription-polymerase chain reaction, Western blot and enzyme-linked immunosorbent assay.

resultsFAQSE decreased the viability of HepG2 and Huh7 cells. There were 211 co-upregulated and 86 co-downregualted genes in both cell lines after FAQSE treatment. The enriched GO terms of co-upregulated DEGs were primarily involved cell-cell adhesion, viral process, transcription initiation from RNA polymerase II promoter, positive regulation of transcription from RNA polymerase II promoter and actin cytoskeleton organization. The GO terms of co-downregulated DEGs were mainly enriched in the processes of SRP-dependent cotranslational protein targeting to membrane, viral transcription, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, translational initiation and rRNA processing. Main KEGG pathways of co-upregulated DEGs were endocytosis, glutathione metabolism, protein processing in endoplasmic reticulum, synaptic vesicle cycle and lysosome. The major KEGG pathways of co-downregulated DEGs were ribosome, biosynthesis of amino acids, arginine and proline metabolism, systemic lupus erythematosus and complement and coagulation cascades. The top 10 co-DEGs with high hub nodes in STRING analysis were ribosomal protein S27a, transferrin, ribosomal protein S20, ribosomal protein L9, protein phosphatase 2 regulatory subunit B alpha, transthyretin, thioredoxin reductase 1, ribosomal protein L3, ribophorin I and ribosomal protein L24. Alpha-fetoprotein (AFP) was also co-downregulated and contained in the PPI network. The mRNA and protein expression of most verified genes was consistent with the results of co-DEGs analysis. And the AFP level was significantly reduced after FAQSE treatment.

conclusionsA series of genes and pathways of HepG2 and Huh7 cells were changed after FAQSE treatment, which might be the targets of FAQSE against HCC and worthy of further study. AFP might be important one of them.

Indexed as

Carcinoma, HepatocellularLiver Neoplasmsalpha-FetoproteinsBiomarkers, TumorCell LineComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansPlant ExtractsRNA, MessengerRNA Polymerase IITranscriptomealpha-FetoproteinsBiomarkers, TumorPlant ExtractsRNA, MessengerRNA Polymerase IIalpha-fetoproteincarcinoma, hepatocellulartranscriptomeYuzhizi seed extract

Identifiers

PMID36378050
PMCPMC9924795
OpenAlexW4309360701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.